Status:

COMPLETED

Resurgence as Choice: Basic and Clinical Studies

Lead Sponsor:

Rutgers, The State University of New Jersey

Collaborating Sponsors:

Utah State University

Conditions:

Problem Behavior

Self-injury

Eligibility:

All Genders

3-19 years

Phase:

NA

Brief Summary

Background: Functional communication training (FCT) is a commonly used intervention for teaching appropriate communication skills to children with intellectual disabilities who exhibit severe destruct...

Detailed Description

Children with intellectual disabilities often display severe destructive behaviors that pose significant risk to self or others and represent barriers to community integration. These destructive behav...

Eligibility Criteria

Inclusion

  • males and females between the ages of 3 and 19;
  • problem behavior (e.g., aggression, property destruction, self-injurious behavior) that has been the focus of outpatient behavioral and pharmacological treatment but continues to occur, on average, more than once per hour;
  • problem behavior reinforced by social consequences (i.e., significantly higher and stable rates of the behavior in one or more social test conditions of a functional analysis \[e.g., attention, escape\] relative to the control condition \[play\] and the test condition for automatic reinforcement \[alone or ignore\]);
  • IQ and adaptive behavior scores between 35 and 70 (i.e., mild to moderate intellectual disability);
  • on a stable psychoactive drug regimen (or drug free) for at least 10 half-lives of each medication with no anticipated changes;
  • stable educational plan and placement, with no anticipated changes during the study.

Exclusion

  • \- Exclusion criteria.
  • children not meeting the inclusion criteria above;
  • children currently receiving intensive (i.e., 15 or more hours per week), function-based, behavioral treatment for their problem behavior through the school or another program;
  • DSM-V diagnosis of Rett syndrome or other degenerative conditions (e.g., inborn error of metabolism);
  • presence of a comorbid health condition (e.g., blindness) or major mental disorder (e.g., bipolar disorder) that would interfere with participation in the study (e.g., requiring frequent hospitalizations);
  • children with self-injurious behavior who, based on the results of the risk assessment, cannot be exposed to baseline conditions without placing them at risk of serious or permanent harm (e.g., detached retinas);
  • children requiring changes in drug treatment (but such children will be invited to participate after they meet the above criteria for a stable drug regimen).

Key Trial Info

Start Date :

June 28 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 2 2023

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT03423940

Start Date

June 28 2018

End Date

August 2 2023

Last Update

September 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rutgers University Center for Autism Research, Education, and Services

Somerset, New Jersey, United States, 08840